Despite wide interest in human genome patents, there has been little information about exactly who owns what. Europe would do well to ponder over the stake already held by Japan and the United States.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cole-Turner, R. Science 270, 52 (1995).
Dixon, D. Nature 378, 425 (1995).
Science 266, 208–210 (1994).
Dixon, D. Nature 379, 574 (1996).
Office of Technology Assessment Biotechnology in a Global Economy (OTA, Washington DC, 1992).
European Commission The European Report on Science and Technology Indicators, 1994 (EUR15897, Brussels, 1994).
Swinbanks, D. Nature 371, 731 (1994).
Thomas, S. M., Kimura, K. & Burke, J. F. Res. Pol. 24, 645–663 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thomas, S., Davies, A., Birtwistle, N. et al. Ownership of the human genome. Nature 380, 387–388 (1996). https://doi.org/10.1038/380387a0
Issue Date:
DOI: https://doi.org/10.1038/380387a0
This article is cited by
-
Patentability of human genes: the conceptual differences between the industrialised and Latin American countries
Journal of Community Genetics (2015)
-
Diagnostic testing fails the test
Nature (2002)
-
Shares in the human genome—the future of patenting DNA
Nature Biotechnology (2002)
-
Patent or perish? An ethical approach to patenting human genes and proteins
The Pharmacogenomics Journal (2002)
-
Patenting human genetic material: refocusing the debate
Nature Reviews Genetics (2000)